XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION AWARDS

The Company has recorded stock-based compensation expense (credit) related to the issuance of stock option awards in the following line items in the accompanying condensed consolidated statement of operations:

 

   2023   2022 
   Three Months Ended
March 31,
 
   2023   2022 
         
Research and development  $11,268   $4,643 
General and administrative   146,345    101,404 
Total stock-based compensation expense  $157,613   $106,047 
SUMMARY OF OPTION ACTIVITY

The following table summarizes stock option activity under the Plan:

 

   Number of
options
   Weighted-average
exercise price
   Weighted-average
remaining
contractual term
(in years)
   Aggregate
intrinsic value
 
Outstanding at December 31, 2022   806,392   $4.33           
Granted                  
Exercised                  
Forfeited                  
Outstanding at March 31, 2023   806,392   $4.33    3.8   $271,298 
                     
Vested and exercisable at March 31, 2023   803,218   $4.31    3.7   $271,298 
SCHEDULE OF FAIR VALUE ASSUMPTIONS

The following table summarizes weighted-average assumptions using the Black-Scholes option-pricing model used on the date of the grants issued during the three months ended March 31, 2022:

 

   2022 
Fair value of Common Stock  $4.62 
Volatility   63.9%
Expected term (years)   6.0 
Risk-free interest rate   2.20%
Dividend yield   0%